CXCL13 and neoplasm: Regarding CXCL13 in tumor cells, there was no difference in OS between patients with low CXCL13 expression (mOS, 9.86 months) and patients with high CXCL13 expression (mOS, 10.88 months; p = 0.270, Figure 4E).